AST SpaceMobile Presents at JPM Conference; Execution Risk Remains Key

What happened

AST SpaceMobile management presented at the J.P. Morgan conference, reiterating the positive FCC SCS authorization for 248 satellites and plans to maintain a launch cadence of one every one to two months. The company continues to scale manufacturing, targeting ~45 BlueBird satellites in orbit by end of 2026. However, the presentation did not disclose new specifics on carrier service activation timelines or the status of the BB7 insurance recovery. The BB7 loss remains a $155-160M write-off overhang, and the upcoming BB8-10 launch (mid-June) is the critical proof point for on-orbit yield. Until AST reports SpaceMobile Service revenue or a successful multi-satellite deployment, the equity remains priced on execution optionality rather than fundamentals.

Implication

The JPM conference did not alter the risk/reward. ASTS remains a high-conviction execution story with a narrow 3-6 month de-risking window. The BB7 loss has reset expectations, and the next 90 days are pivotal. If BB8-10 launches successfully and Q2 shows progress on insurance and service activation, the stock could re-rate toward $90-125. If delays continue, the bear case of $50 becomes more probable. Investors should maintain positions only if comfortable with binary launch risk and potential dilution.

Thesis delta

No change to the thesis; execution remains the sole driver. The conference presentation offered no new information modulating the WAIT call.